Research Chemicals BK MDMA
Research Chemicals BK MDMA Methylone ((3,4-methylenedioxy)methcathinone) is a synthetic cathinone. It is the beta-keto
version of 3,4-methylenedioxymethylamphetamine (mdma). It was originally developed as a
therapeutic for Parkinson’s disease or depression by Shulgin. Use of methylone was first
reported around 2005. Use/abuse has been reported from Japan, the USA and Europe. The effects and the mode of use reported have similarities with mdma, but its potency is less.
Reported toxic effects of methylone include tachycardia, hypertension, paranoia, anxiety, bruxism and muscle tension and aching. Some of these effects leeding to hospital admissions.
A number of analytically confirmed drug-related deaths have been reported.
Animal studies have indicated that methylone possesses an abuse or dependence potential but there are no human clinical data to support this.